Penumbra(PEN) - 2023 Q3 - Earnings Call Transcript

Mike Matson Adam Elsesser Okay. Thanks. And then the one thing that surprised us in â23 was just the strength on the neuro side. I mean clearly, vascular it looked like it was going to do well given the product cycle. But Thunderbolt has been delayed. So, what I am wondering is looking into next year, do you have anything new coming in neuro to kind of help drive the growth there in â24? Yes. I will start with â we always have new products in both fields, neuro as well. I am not going to comment on them. Th ...